Premium
Sodium–glucose co‐transporter 2 inhibitors in heart failure with preserved ejection fraction: reasons for optimism
Author(s) -
Anker Stefan D.,
Khan Muhammad Shahzeb,
Shahid Izza,
Filippatos Gerasimos,
Coats Andrew J.S.,
Butler Javed
Publication year - 2021
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1002/ejhf.2279
Subject(s) - medicine , heart failure , heart failure with preserved ejection fraction , empagliflozin , ejection fraction , cardiology , dapagliflozin , pathophysiology , diabetes mellitus , population , intensive care medicine , type 2 diabetes , endocrinology , environmental health
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom